Bio-View Ltd (TLV:BIOV)

Israel · Delayed Price · Currency is ILS · Price in ILA

80.60

+0.10 (0.12%)

Sep 10, 2026, 5:24 PM IDT

Market Cap	10.80M -58.9%
Revenue (ttm)	20.70M +15.8%
Net Income	-13.11M
EPS	-0.94
Shares Out	13.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,027
Open	80.60
Previous Close	80.50
Day's Range	80.60 - 80.70
52-Week Range	79.00 - 294.00
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 30, 2026

About Bio-View

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company’s products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies var... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 31

Stock Exchange Tel Aviv Stock Exchange

Ticker Symbol BIOV

Full Company Profile

Financial Performance

In 2025, Bio-View's revenue was 19.93 million, a decrease of -22.32% compared to the previous year's 25.66 million. Losses were -15.33 million, 387.0% more than in 2024.

Financial Statements